. Mass Eye and Ear research fellow Cherrell Price is presenting at this afternoon's poster session and will share how genetic data reanalysis can help reduce the missed diagnosis of inherited retinal disorders. #ARVO2024

Poster # B0182

Yuyang Luo will be presenting today at 2:15pm in Room 6E #ARVO2024 on a Pharmacogenetic study of anti-VEGF response in DME lead by Dr. Sobrin and myself Ayellet Segrè Harvard Ophthalmology Mass Eye and Ear. A wonderful collaboration with the DRCR Retina network @drcrNet and Regeneron Genetics Center.

I'm honored to present research results at #ARVO2024 , at 'Solving the missing heritability' session, so please come and join, if you are interested. May 8, 3:30 pm Tahoma 3. Harvard Ophthalmology Harvard Medical School Broad Institute

Such a great Harvard Alumni reception! So nice catching up with my amazing mentors and colleagues! 🥰 Harvard Ophthalmology ARVO #arvo2024 Saint_Geniez_Lab

Research fellow Yeganeh Farsi, MD, MPH, MBA presented her poster assessing ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation and tapering of immunomodulatory therapy. Great work! ARVO #ARVO2024

Sharing our new work from Harvard Ophthalmology/Mass Eye and Ear on #qCSF contrast sensitivity across #DiabeticRetinopathy stages strongly correlating with progressive microvascular changes on #OCTA

#retina #endpoints Mary Tyler Moore Vision Initiative
John B. Miller Ophthalmology at BMJ #ophthalmology bjo.bmj.com/content/early/…

Research fellow Dr. Shima Dehghani is presenting at this morning's paper session on how blocking IL-6 could potentially improve the success rate of graft survival in high-risk corneal transplantations. #ARVO2024

Poster # A0072

Our Harvard Ophthalmology AI Lab at ARVO 2024. Each year, I always take a photo with my admired role model and mentor in eye research Dr. Donald Hood. #ARVO2024

Clinical trial results published today in NEJM show that CRISPR-Cas9 gene editing is safe and helped improve the vision of 11 of 14 participants who suffer from inherited retinal disorders. Congratulations to lead investigator Dr. Eric Pierce and his team! #GeneEditing

The vision of 22-year-old Olivia Cook has improved, and so has her hope for the future thanks to an experimental gene-editing treatment called #CRISPR . Learn more about the groundbreaking study from lead investigator Eric Pierce, MD, PhD: spklr.io/6019U6AP via CNN.

Congratulations to alumnus Dr. David Zacks, recipient of the ARVO Kreissig Award for Excellence in Retinal Surgery! #ARVO2024

U-M Kellogg Eye Center

Trainee and Sarla and Piyush Kothary Memorial Travel Grant recipient, Renee Liu, presented her project investigating genetic risk factors for proliferative diabetic retinopathy in under-represented populations. Great work!